Plasma and Dietary Linoleic Acid and 3-Year Risk of Type 2 Diabetes After Myocardial Infarction: A Prospective Analysis in the Alpha Omega Cohort
- 14 November 2019
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (2), 358-365
- https://doi.org/10.2337/dc19-1483
Abstract
OBJECTIVE To study plasma and dietary linoleic acid (LA) in relation to type 2 diabetes risk in post–myocardial infarction (MI) patients. RESEARCH DESIGN AND METHODS We included 3,257 patients aged 60–80 years (80% male) with a median time since MI of 3.5 years from the Alpha Omega Cohort and who were initially free of type 2 diabetes. At baseline (2002–2006), plasma LA was measured in cholesteryl esters, and dietary LA was estimated with a 203-item food-frequency questionnaire. Incident type 2 diabetes was ascertained through self-reported physician diagnosis and medication use. Hazard ratios (with 95% CIs) were calculated by Cox regressions, in which dietary LA isocalorically replaced the sum of saturated (SFA) and trans fatty acids (TFA). RESULTS Mean ± SD circulating and dietary LA was 50.1 ± 4.9% and 5.9 ± 2.1% energy, respectively. Plasma and dietary LA were weakly correlated (Spearman r = 0.13, P < 0.001). During a median follow-up of 41 months, 171 patients developed type 2 diabetes. Plasma LA was inversely associated with type 2 diabetes risk (quintile [Q]5 vs. Q1: 0.44 [0.26, 0.75]; per 5%: 0.73 [0.62, 0.86]). Substitution of dietary LA for SFA+TFA showed no association with type 2 diabetes risk (Q5 vs. Q1: 0.78 [0.36, 1.72]; per 5% energy: 1.18 [0.59, 2.35]). Adjustment for markers of de novo lipogenesis attenuated plasma LA associations. CONCLUSIONS In our cohort of post-MI patients, plasma LA was inversely related to type 2 diabetes risk, whereas dietary LA was not related. Further research is needed to assess whether plasma LA indicates metabolic state rather than dietary LA in these patients.This publication has 36 references indexed in Scilit:
- Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysisBritish Journal of Nutrition, 2012
- Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health StudyThe American Journal of Clinical Nutrition, 2011
- Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)–Potsdam StudyThe American Journal of Clinical Nutrition, 2011
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionThe New England Journal of Medicine, 2010
- Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)–Norfolk cohortThe American Journal of Clinical Nutrition, 2010
- Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega TrialAmerican Heart Journal, 2010
- Dose‐response analyses using restricted cubic spline functions in public health researchStatistics in Medicine, 2010
- Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet.JCI Insight, 1996
- Reproducibility of a semiquantitative food frequency questionnaire to assess the intake of fats and cholesterol in The NetherlandsInternational Journal of Food Sciences and Nutrition, 1995
- Effect of the Membrane Lipid Environment on the Properties of Insulin ReceptorsDiabetes, 1981